Clinical Impact of Clonal and Subclonal TP53 M... - CLL Support

CLL Support

23,324 members40,026 posts

Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia

7 Replies

You need to be a member of this community to see this post.

7 Replies

You need to be a member of this community to see hidden responses.

Not what you're looking for?

You may also like...

Chronic lymphocytic leukemia treatment algorithm 2022

This 29 November 2022 review article published in the Blood Cancer Journal presents an...
CLLerinOz profile image
Administrator

Clonal Evolution, mutations and resistance to CLL treatment

When someone is diagnosed with CLL they have at least one clone of B lymphocytes that are growing...
AdrianUK profile image

VenR in Relapsed CLL: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations from MURANO 3 study

This is an important evaluation and insight into how your CLL profile affects your response to VR...
Jm954 profile image
Administrator

"Accelerated" chronic lymphocytic leukemia/small lymphocytic lymphoma: unraveling CLL/SLL biological gray zone in the era of novel therapies

Encouraging news in this abstract from CLL/SLL researchers at the Northwestern Memorial Hospital,...
AussieNeil profile image
Partner

Clinical trial results on 17p & tp53 variants in treatment naïve & relapsed patients by Dr. Furman - Oct 2022 to medical professionals

This link: https://hmpeducation.com/content/access-webcast-133 will connect to a talk by Dr....
lankisterguy profile image
Volunteer